Advisory: Research alert on Kailera Therapeutics withdrawn
14/05/2026 06:25
May 14 (Reuters) - An alert on TD Cowen starting coverage on Kailera Therapeutics Inc KLRA.O is dated and has been withdrawn. There will be no substitute. STORY_NUMBER:FWN41R08Z STORY_DATE:14/05/2026 STORY_TIME:[05:08:26] ((Bangalore.newsroom@thomsonreuters.com))
Recent news on Kailera Therapeutics
See all newsChina biotech's ingenuity extends to dealmaking
Factbox: Weight-loss drug developers line up to tap lucrative market as competition heats up
China biotech's ingenuity extends to dealmaking
Factbox: Weight-loss drug developers line up to tap lucrative market as competition heats up
Brief: Kailera Therapeutics Announces Completion Of Enrollment In Kainetic Global Phase 3 Clinical Program Of Glp-1/Gip Receptor Dual Agonist Ribupatide Injection